Cargando…

Design and Evaluation of Peptide Dual-Agonists of GLP-1 and NPY2 Receptors for Glucoregulation and Weight Loss with Mitigated Nausea and Emesis

[Image: see text] There is a critical unmet need for therapeutics to treat the epidemic of comorbidities associated with obesity and type 2 diabetes, ideally devoid of nausea/emesis. This study developed monomeric peptide agonists of glucagon-like peptide 1 receptor (GLP-1R) and neuropeptide Y2 rece...

Descripción completa

Detalles Bibliográficos
Autores principales:	Milliken, Brandon T., Elfers, Clinton, Chepurny, Oleg G., Chichura, Kylie S., Sweet, Ian R., Borner, Tito, Hayes, Matthew R., De Jonghe, Bart C., Holz, George G., Roth, Christian L., Doyle, Robert P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2021
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7956155/ https://www.ncbi.nlm.nih.gov/pubmed/33449689 http://dx.doi.org/10.1021/acs.jmedchem.0c01783

Ejemplares similares

RF04 | PSUN295 Evolution of Monomeric Multi-Agonists of GLP-1 and NPY Receptors
por: Chichura, Kylie, et al.
Publicado: (2022)

A peptide triple agonist of GLP-1, neuropeptide Y1, and neuropeptide Y2 receptors promotes glycemic control and weight loss
por: Chichura, Kylie S., et al.
Publicado: (2023)

The Role of GIP in the Regulation of GLP-1 Satiety and Nausea
por: Hayes, Matthew R., et al.
Publicado: (2021)

SUN-660 Appetite Suppressing Effects of Glucoregulatory Chimeric Peptides Devoid of Nausea
por: Roth, Christian Ludwig, et al.
Publicado: (2020)

GIP Receptor Agonism Attenuates GLP-1 Receptor Agonist–Induced Nausea and Emesis in Preclinical Models
por: Borner, Tito, et al.
Publicado: (2021)

Chimeric peptide EP45 as a dual agonist at GLP-1 and NPY2R receptors
por: Chepurny, Oleg G., et al.
Publicado: (2018)

Synthesis, Optimization, and Biological Evaluation of Corrinated Conjugates of the GLP-1R Agonist Exendin-4
por: Tinsley, Ian C., et al.
Publicado: (2021)

Publisher Correction: Chimeric peptide EP45 as a dual agonist at GLP-1 and NPY2R receptors
por: Chepurny, Oleg G., et al.
Publicado: (2018)

Pheochromocytoma and Glucoregulation Disorders
por: Derrou, Sara, et al.
Publicado: (2021)

Evaluation of nausea and vomiting in pregnancy using the Pregnancy-Unique Quantification of Emesis and Nausea scale in Korea
por: Choi, Hyun Joung, et al.
Publicado: (2018)

The importance of systematic approaches in the study of emesis
por: De Jonghe, Bart C, et al.
Publicado: (2015)

GIP receptor agonism blocks chemotherapy-induced nausea and vomiting
por: Borner, Tito, et al.
Publicado: (2023)

The Emesis Trial: Depressive Glioma Patients Are More Affected by Chemotherapy-Induced Nausea and Vomiting
por: Dufner, Vera, et al.
Publicado: (2022)

The involvement of TRPV1 in emesis and anti-emesis
por: Rudd, John A, et al.
Publicado: (2015)

Behavioral Patterns Associated with Chemotherapy-Induced Emesis: A Potential Signature for Nausea in Musk Shrews
por: Horn, Charles C., et al.
Publicado: (2011)

Sleep Disturbances and Glucoregulation in Patients with Type 2 Diabetes
por: Cho, Eun-Hee, et al.
Publicado: (2014)

Assessment of low-dose cisplatin as a model of nausea and emesis in beagle dogs, potential for repeated administration
por: Kenward, Hannah, et al.
Publicado: (2014)

Anticipatory nausea and emesis, and psychological morbidity: assessment of prevalence among out-patients on mild to moderate chemotherapy regimens.
por: Watson, M., et al.
Publicado: (1992)

Creation of a Peptide Antagonist of the GFRAL–RET Receptor Complex for the Treatment of GDF15-Induced Malaise
por: Borner, Tito, et al.
Publicado: (2023)

Systemic Glucoregulation by Glucose-Sensing Neurons in the Ventromedial Hypothalamic Nucleus (VMH)
por: Shimazu, Takashi, et al.
Publicado: (2017)

Caffeine-Containing Energy Shots Cause Acute Impaired Glucoregulation in Adolescents
por: Shearer, Jane, et al.
Publicado: (2020)

GIPR Agonism Inhibits PYY-Induced Nausea-Like Behavior
por: Samms, Ricardo J., et al.
Publicado: (2022)

Intra-islet glucagon confers β-cell glucose competence for first-phase insulin secretion and favors GLP-1R stimulation by exogenous glucagon
por: Cabrera, Over, et al.
Publicado: (2021)

Chewing gum to treat postoperative nausea and emesis in female patients (CHEWY): rationale and design for a multicentre randomised trial
por: Darvall, Jai, et al.
Publicado: (2019)

Surveying the effect of a self-care education program on severity of nausea and emesis in colorectal cancer patients under chemotherapy
por: Karimi, Saba, et al.
Publicado: (2017)

Rare causes of emesis
por: Popa, Stefan L., et al.
Publicado: (2020)

Emesis in a Horse
por: Lowe, William Herbert
Publicado: (1884)

Energy Balance in Hypothalamic Obesity in Response to Treatment with a Once-Weekly GLP-1 Receptor Agonist
por: Shoemaker, Ashley H., et al.
Publicado: (2022)

A sweet spot for the sleeping brain: Linking human sleep physiology and glucoregulation
por: Niethard, Niels, et al.
Publicado: (2023)

Synthetic small molecule GLP-1 secretagogues prepared by means of a three-component indole annulation strategy
por: Chepurny, Oleg G., et al.
Publicado: (2016)

Reduction of carboplatin induced emesis by ondansetron.
por: Harvey, V. J., et al.
Publicado: (1991)

Single nuclei RNA sequencing of the rat AP and NTS following GDF15 treatment
por: Reiner, Benjamin C., et al.
Publicado: (2021)

Receptor-specific recognition of NPY peptides revealed by structures of NPY receptors
por: Tang, Tingting, et al.
Publicado: (2022)

Effects of Methylphenidate on Weight Gain and Food Intake in Hypothalamic Obesity
por: Elfers, Clinton Thomas, et al.
Publicado: (2011)

β-Cell Inactivation of Gpr119 Unmasks Incretin Dependence of GPR119-Mediated Glucoregulation
por: Panaro, Brandon L., et al.
Publicado: (2017)

Principal component analysis of the oxidative stress, inflammation, and dyslipidemia influence in patients with different levels of glucoregulation
por: Malenica, Maja, et al.
Publicado: (2023)

Cannabinoid Hyper-emesis Syndrome: An Enigma
por: Gupta, Neeraj, et al.
Publicado: (2013)

Morphia and Cocaine in Emesis Gravidarum and Abortion
por: MacVie, S.
Publicado: (1901)

A Modified Mediterranean Diet Improves Fasting and Postprandial Glucoregulation in Adults with Overweight and Obesity: A Pilot Study
por: Gioxari, Aristea, et al.
Publicado: (2022)

A role for NPY-NPY2R signaling in albuminuric kidney disease
por: Lay, Abigail C., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vc2qn7rrle3cov75sv4uml426t